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Abstract. Blood coagulation is part of an important host defence mechanism termed 
hemostasis. In vitro evaluation of this complex process implies assessment of several factors and 
proteins generally known as coagulation profile. The purpose of this study was to determine the 
reference rage values for prothrombin time (PT) and activated partial thromboplastin time (aPTT) in 
normal dogs. These determinations were made on 40 healthy male and female dogs from various 
breeds, which were divided in two groups based on their age: under 1.5 years old (n=15) and over 1.5 
years old (n=25). The PT and aPTT values were established using a KC-1A semiautomatic 
coagulometer and commercially available kit for human medicine. The rage value for aPTT in 1.5 
years old dogs was 16.74± 0.35 sec, while for the adult dogs it was 12.36 ± 0.68 sec. Also, PT rage 
value was 5.3±0.63 sec in adult dogs and 5.7±0.4 sec in young dogs. In the experimental conditions 
mentioned previously, the human commercial kits proved their utility in establishing reference values 
of two coagulation parameters in dog. 
 




 Coagulation abnormalities in small animal practice are mainly acquired and along with 
the hereditary deficiencies of coagulation factors represent an important pathology due to 
their implications: exaggerated hemorrhagic tendency, spontaneous, multifocal, unexpected 
severe bleeding and even life-threatening haemorrhages. 
 Screening tests evaluating the plasma coagulation pathways such as activated partial 
thromboplastin time (aPTT) and prothrombin time (PT) are useful tools in accurately 
identifying the abnormality and in initiating and monitoring therapy to correct the disorder. 
The PT screens for abnormalities in the extrinsic and common pathways of coagulation 
(plasma factors VII, X, V, prothrombin, and fibrinogen), while aPTT evaluates plasma for 
abnormalities in factors of the intrinsic and common pathways (prekallikrein; factors XII, XI, 
IX, VIII, X, and V; prothrombin; fibrinogen). The PTT tests for deficiencies of all clotting 
factors except factor VII (measured by the PT) and factor XIII (Lopez et al., 2005).  
 PT and aPTT reference values reported by several authors vary as there are obtained 
using different reagents and methods. Therefore, as suggested by literature, each laboratory 
must establish mean normal values for these parameters (Lopez et al., 2005; Mischke, 1995, 
2001, 2002). 
 The objective of this experiment was to determine the reference range values of 
prothrombin time (PT) and activated partial thromboplastin time (aPTT). Human commercial 
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kits were used because there are no available veterinary kits for this purpose and also because 
several studies indicated the high sensitivity of these reagents for canine plasma.  
 
MATERIALS AND METHODS 
 
 The determinations were made on 40 healthy male and female dogs from various 
breeds that were divided in two groups based on their age: under 1.5 years old (n=15) and 
over 1.5 years old (n=25). The blood samples were taken from the cephalic or saphenous vein 
using sterile vacutainers containing 3,8% sodium citrate solution, 1 in 9 final citrate: blood 
ratio, and centrifugated at 2500 rpm for 10 min; the obtained platelet - poor citrated plasma 
was stored at -200C, to avoid the cryoprecipitation of coagulation factors. Undiluted plasma 
samples were analysed using a KC-1A semiautomatic coagulometer and commercially 
available reagents for human medicine (TeClot-QuickS). The authors consider that these kits 
are suitable for veterinary laboratory determinations also, as they present a high sensitivity. 
Measurements for the two coagulation parameters were performed in duplicate and according 
to the instructions of the manufacturer. 
 
RESULTS AND DISCUSSION 
 
 References intervals for prothrombin time (PT) and activated partial thromboplastin 
time (aPTT) of undiluted citrated canine plasma determined using a KC-1A semiautomatic 
coagulometer and human kits (TeClot-QuickS) are presented in tables no. 1 - 4. Differences 
between duplicate were less than 5%.  
 
Tab. 1 
Activated partial thromboplastin time (aPTT) values in young dogs   
 
aPTT values (sec) 
 Breed Age Gender Test 1 Test  2 Average 
1 German Shepherd Dog 1 year male 17.2 17.2 17.2 
2 German Braque 1 year female 16.9 16.7 16.8 
3 German Braque 9 months female 16.2 16.4 16.3 
4 German Shepherd Dog 7 months male 17.3 17.3 17.3 
5 Mixed breed 7 months female 17.1 17.1 17.1 
6 Mixed breed 6 months female 16.4 16.4 16.4 
7 Mixed breed 6 months male 16.3 16.5 16.4 
8 Mixed breed 6 months male 16.9 16.7 16.8 
9 Mixed breed 6 months female 16.5 16.5 16.5 
10 Doberman 9 months male 16.9 16.9 16.9 
11 German Shepherd Dog 10 months female 16.4 16.6 16.5 
12 Mixed breed 7 months female 16.5 16.3 16.4 
13 Mixed breed 8 months male 17.0 17.0 17.0 
14 Mixed breed 10 months male 16.4 16.2 16.3 
15 Mixed breed 1 year female 17.0 17.0 17.0 










Activated partial thromboplastin time (APTT) values in adult dogs   
 
APTT values (sec) 
 Breed Age Gender Test 1 Test  2 Average 
1 Mixed breed 5 years male 11.0 11.0 11.0 
2 Mixed breed 4 years female 11.4 11.8 11.6 
3 German Shepherd Dog 3 years male 11.3 11.5 11.4 
4 Mixed breed 2 years female 12.4 12.6 12.5 
5 Amstaff 6 years female 13.5 13.5 13.5 
6 German Shepherd Dog 3 years female 11.5 11.6 11.6 
7 Bull Terrier 3 years male 13.2 13.2 13.2 
8 Caniche 2 years female 11.3 11.3 11.3 
9 German Braque 4 years male 13.2 13.0 13.1 
10 Terra Nova 3 years male 12.2 12.0 12.1 
11 Belgian Shepherd   2 years female 12.7 12.7 12.7 
12 German Shepherd Dog 4 years male 12.7 12.9 12.8 
13 Schnauzer 4 years male 12.7 12.9 12.8 
14 Mixed breed 4 years female 12.2 12.2 12.2 
15 Mixed breed 2,5 years female 11.8 11.8 11.8 
16 German Shepherd Dog 3 years female 13.1 13.1 13.1 
17 Mixed breed 3 years male 12.4 12.4 12.4 
18 German Shepherd Dog 4 years female 11.8 11.8 11.8 
19 Cocker 7 years male 12.3 12.5 12.4 
20 Mixed breed 2,5 years female 12.8 12.8 12.8 
21 Mixed breed 3 years male 11.5 11.7 11.6 
22 Mixed breed 6 years female 13.1 13.1 13.1 
23 Mixed breed 4 years female 12.8 12.8 12.8 
24 Mixed breed 2 years male 13.0 13.0 13.0 
25 Mixed breed 3 years female 12.5 12.7 12.6 
Reference value 12.3±0.68 
 
Tab. 3 
Prothrombin time values (PT) values in young dogs 
 
PT values (sec) Nr Breed Age Gender Test  2 Average Test  2 
1 German Shepherd Dog 1 year male 5.4 5.2 5.3 
2 German Braque 1 year female 5.4 5.4 5.4 
3 Alaska Malamut  9 months female 6.1 6.3 6.2 
4 German Shepherd Dog 7 months male 6.3 6.3 6.3 
5 Mixed breed 7 months female 5.1 5.3 5.2 
6 Mixed breed 6 months female 5.3 5.3 5.3 
7 Mixed breed 6 months male 5.2 5.2 5.2 
8 Mixed breed 6 months male 5.2 5.2 5.2 
9 Mixed breed 6 months female 5.5 5.3 5.4 
10 Doberman 9 months male 6.3 6.3 6.3 
11 German Shepherd Dog 10 months female 6.5 6.5 6.5 
12 Mixed breed 7 months female 5.4 5.6 5.5 
13 Mixed breed 8 months male 6.0 6.2 6.1 
14 Mixed breed 10 months male 5.7 5.9 5.8 
15 Mixed breed 1 year female 6.2 6.2 6.2 
Reference value 5.7±0.48 
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The rage value for aPTT in 1.5 years old dogs was 16.74± 0.35 sec, with a minimum 
and maximum of 16.3 and 17.3 sec, respectively (table 1). In adult dogs the same parameter 
was 12.36 ± 0.68 sec, with the reference interval between 11 and 13.5 (table 2). 
 Also, PT rage value was 5.7±0.4 sec in young dogs and 5.3±0.63 sec in adult dogs. 
 The reference intervals were established in young dogs and in adult dogs for 5.2-6.5 
and 4.4-6.4sec, respectively. 
 These rage values and the reference intervals were compared with other two similar 
studies, results shown in table 5.  
 
Tab.4 
Prothrombin time values (PT) values in adult dogs   
 
PT values (sec) 
 Breed Age Gender Test 1 Test 1 Test 1 
1 Mixed breed 5 years male 4.6 4.8 4.7 
2 Mixed breed 4 years female 5.7 5.7 5.7 
3 German Shepherd Dog 3 years male 5.6 5.6 5.6 
4 Mixed breed 2 years female 5.6 5.8 5.7 
5 Amstaff 6 years female 4.5 4.5 4.5 
6 German Shepherd Dog 3 years female 4.3 4.5 4.4 
7 Bull Terrier 3 years male 6.4 6.4 6.4 
8 Caniche 2 years female 5.0 5.0 5.0 
9 German Braque 4 years male 4.5 4.5 4.5 
10 Terra Nova 3 years male 4.6 4.6 4.6 
11 Belgian Shepherd 2 years female 5.2 5.4 5.3 
12 German Shepherd Dog 4 years male 4.8 5.0 4.9 
13 Schnauzer 4 years male 5.1 5.1 5.1 
14 Mixed breed 4 years female 5.3 5.5 5.4 
15 Mixed breed 2,5 years female 6.0 6.2 6.1 
16 German Shepherd Dog 3 years female 5.1 5.1 5.1 
17 Mixed breed 3 years male 6.1 6.1 6.1 
18 German Shepherd Dog 4 years female 6.2 6.4 6.3 
19 Cocker 7 years male 5.6 5.8 5.7 
20 Mixed breed 2,5 years female 4.8 4.6 4.7 
21 Mixed breed 3 years male 4.5 4.5 4.5 
22 Mixed breed 6 years female 6.0 6.0 6.0 
23 Mixed breed 4 years female 5.5 5.5 5.5 
24 Mixed breed 2 years male 5.8 5.6 5.7 
25 Mixed breed 3 years female 6.0 6.2 6.1 
Reference value 5.3±0.63 
 
Tab.5 
The study results compared with two similar researches 
 aPTT (sec) PT (sec) 
 Rage value Reference interval Rage value Reference interval 
Young dogs 16.74±0.35 16.3-17.3 5.72±0.48 5.2-6.5 
Adult dogs 12.36±0.68 11-13.5 5.3±0.63 4.4-6.4 
Lopes et al., 2005* 15.10±1.6 11.9-18.3 6.87±1.4 4.07-9.67 
Vlasin et al., 2004* 11.65±1.54 9.5-10.5 8.12±0.48 6.4-7.4 
*same method, different reagents compared with the present study 
 
 The clinical laboratory evaluation is an integral part of the diagnosis and management 
of patients with hemostatic/thrombotic disorders. Among laboratory screening tests, aPTT and 
PT are the fundamental assays of the coagulation system.  
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 The PT screens for abnormalities in the extrinsic and common pathways of 
coagulation (plasma factors VII, X, V, prothrombin, and fibrinogen), while aPTT evaluates 
plasma for abnormalities in factors of the intrinsic and common pathways (prekallikrein; 
factors XII, XI, IX, VIII, X, and V; prothrombin; fibrinogen). Prothrombin Time is sensitive 
to a reduction in three of four Vitamin K- dependent procoagulant proteins (VII, X and II) and 
the most common reason for a prolonged PT in the face of a normal aPTT is an acquired 
“deficiency” due to warfarin (coumadin) therapy. In addition, taking into account the fact that 
the factors VII, II, X, and V are synthesized in the liver, a prolonged PT in general correlates 
well with the severity of hepato-cellular damage as well as with the occurrence of bleeding 
(Badylak and Van Vleet, 1991; Lopez et al., 2005; Vlasin et al., 2004).  
 Most commonly, a prolonged aPTT is induced by heparin that can be introduced as a 
therapeutic or as a contaminant. Therefore, this test is used to monitor levels of anticoagulant 
therapy. Also, a deficiency of the intrinsic pathway or contact factors will result in a 
prolonged aPTT that will show a correction to within the aPTT reference range upon addition 
of 50% normal pooled plasma. If the PT is normal, then a prolonged aPTT is due to a 
deficiency of factors VIII (Hemophilia A and von Willebrand Disease), IX and XI. 
Prolongation of both aPTT and PT suggests a deficiency or inhibition of the common pathway 
coagulation factors (factor X, V, and II), or a qualitative or quantitative fibrinogen defect 
(Badylak and Van Vleet, 1991; Mischke, 1995; Lopez et al., 2005; Vlasin et al., 2004). 
 The principal clinical uses of the aPTT include: the detection of hereditary or acquired 
deficiencies or defects of the intrinsic and common pathway coagulation factors (factors XII, 
XI, IX, VIII, prekallikrein, high molecular weight kininogen); monitoring heparin 
anticoagulant therapy; the detection of coagulation inhibitors (i.e., lupus anticoagulant), and 
(4) to monitor coagulation factor replacement therapy in patients with hemophilia (Badylak 
and Van Vleet, 1991; Mischke, 1995; Lopez et al., 2005; Vlasin et al., 2004). 
 PT and aPTT reference values reported by several authors vary. It is well known that 
the results of hemostasis evaluation may be affected by a wide variety of factors, including 
the manner of blood coagulation, the type of container, the type of anticoagulant, specimen 
transport and storage conditions, incubation time and temperature, assay reagents, and the 
method of end point detection (Mischke, 1995, 2001, 2002; Mischke and Nolte, 1997; Tseng 
et al., 2001). Therefore, as suggested by literature, each laboratory must establish mean 
normal values and the references intervals for these parameters and to standardize the 
methods (Hartman and Conley, 1992; Lopez et al., 2005; Mischke, 1995, 2001, 2002).  
 This study was intended to determine the references intervals for prothrombin time 
(PT) and activated partial thromboplastin time (aPTT), as these tests are fundamental assays 
in hemostasis, pointing out the minimum of coagulation process. Our results are similar to 




1. aPTT and PT represent fundamental tests in coagulasis exploratory assays, as part of 
homeostasis minimum survey. 
2. These tests allow the diagnosis for hereditary or acquired coagulopathies, warfarin 
intoxication, disseminated intravascular coagulopathy and to monitor heparin therapy. 
3. PT and aPTT reference values may be affected by a wide variety of factors, including the 
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